Physician profile
Scott E Walker
NPI 1386616910
$410.50
in general payments reported to CMS, 2019-2025
17 companies · $28.93 in 2025
The $28.93 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $13.80 · 2021: $51.69 · 2022: $103 · 2023: $14.34 · 2024: $14.37 · 2025: $28.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $57.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $57.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $51.53 | 2019-2021 | |
| Organon LLC | $44.76 | 2022 | |
| Roche Diagnostics Corporation | $35.69 | 2019 | |
| Myovant Sciences INC. | $35.08 | 2022 | |
| Biogen, INC. | $28.93 | 2025 | Zurzuvae |
| Sanofi Pasteur INC. | $23.76 | 2019 | |
| Aspira Women'S Health INC | $23.30 | 2022 | |
| Coopersurgical, INC. | $20.81 | 2021 | |
| Amag Pharmaceuticals, INC. | $19.92 | 2019 | |
| Amgen INC. | $18.61 | 2019 | |
| Alexion Pharmaceuticals, INC. | $18.00 | 2019 | |
| Merck Sharp & Dohme LLC | $17.73 | 2019 | |
| Boston Scientific Corporation | $16.32 | 2021 | |
| Vertical Pharmaceuticals, LLC | $15.50 | 2019 | |
| Hologic Sales and Service, LLC | $14.37 | 2024 | Aptima |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $14.34 | 2023 | Veozah |
| Lupin INC. | $11.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.